Learn More
7045 Background: To compare the activity and tolerability of the sequential versus the alternate administration of cisplatin-etoposide and topotecan in patients with previously untreated extensive(More)
INTRODUCTION Thirty to 40% of patients with non-small cell lung cancer (NSCLC) are older than 70 years and rarely are enrolled in clinical trials. Moreover, in clinical practice, > 75% of patients(More)
BACKGROUND This trial was designed to compare the efficacy and toxicity of sequential versus alternating administration of cisplatin/etoposide and topotecan in patients with previously untreated(More)